BPCE
VRTX icon

Bank Pictet & Cie (Europe)’s Vertex Pharmaceuticals VRTX Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$691K Buy
1,392
+870
+167% +$386K 0.01% 150
2026
Q1 		$233K Buy
522
+40
+8% +$18.7K 0.01% 196
2025
Q4 		$219K Buy
+482
New +$208K ﹤0.01% 194
2024
Q3 		– Sell
-742
Closed -$348K – 161
2024
Q2 		$348K Sell
742
-296
-29% -$128K 0.01% 130
2024
Q1 		$434K Sell
1,038
-69
-6% -$29.2K 0.01% 138
2023
Q4 		$450K Sell
1,107
-42
-4% -$15.5K 0.01% 198
2023
Q3 		$400K Sell
1,149
-15
-1% -$5.25K 0.01% 188
2023
Q2 		$410K Sell
1,164
-1,159
-50% -$391K 0.01% 197
2023
Q1 		$732K Buy
2,323
+442
+23% +$133K 0.03% 120
2022
Q4 		$543K Sell
1,881
-726
-28% -$221K 0.03% 118
2022
Q3 		$755K Sell
2,607
-599
-19% -$172K 0.04% 109
2022
Q2 		$903K Sell
3,206
-1,732
-35% -$464K 0.04% 101
2022
Q1 		$1.29M Sell
4,938
-13,304
-73% -$3.16M 0.05% 98
2021
Q4 		$4.01M Sell
18,242
-555
-3% -$108K 0.14% 73
2021
Q3 		$3.41M Sell
18,797
-34,154
-65% -$6.67M 0.13% 77
2021
Q2 		$10.7M Buy
52,951
+36,560
+223% +$7.65M 0.37% 53
2021
Q1 		$3.52M Sell
16,391
-52,409
-76% -$11.5M 0.14% 79
2020
Q4 		$16.3M Buy
68,800
+18,641
+37% +$4.28M 0.8% 38
2020
Q3 		$13.6M Buy
+50,159
New +$13.8M 0.77% 36
2019
Q1 		– Sell
-4,200
Closed -$696K – 164
2018
Q4 		$696K Buy
+4,200
New +$728K 0.14% 70

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s VRTX Position: Q2 2026 in Review

Bank Pictet & Cie (Europe) increased its Vertex Pharmaceuticals (VRTX) stake by 167% in Q2 2026, buying an estimated $386K and bringing the position to 1,392 shares worth $691K. The position accounts for 0.01% of the portfolio, ranked #150.

Bank Pictet & Cie (Europe) first reported a position in VRTX in Q4 2018 and has held it in 20 quarters since. The position peaked at $16.3M in Q4 2020. 1,217 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Bank Pictet & Cie (Europe) held 1,392 shares of Vertex Pharmaceuticals worth $691K as of Q2 2026.
  • Bank Pictet & Cie (Europe) bought 870 Vertex Pharmaceuticals shares in Q2 2026, an estimated $386K.
  • Vertex Pharmaceuticals made up 0.01% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #150 holding.
  • Bank Pictet & Cie (Europe) first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 20 quarters since.
  • Bank Pictet & Cie (Europe)'s Vertex Pharmaceuticals position peaked at $16.3M in Q4 2020.
  • 1,217 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.